Literature DB >> 21059445

Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome.

Christopher C Draheim1, Justin R Geijer, Donald R Dengel.   

Abstract

Adults with Down syndrome (DS) residing in large institutional settings possess low levels of atherosclerosis. The purpose of this study was to determine whether community-residing adults with DS possess less atherosclerosis than adults without DS. The second purpose was to examine the relation between cardiovascular disease risk factors and intima-media thickness (IMT), a measure of atherosclerosis, in patients with DS. B-mode images of the left common carotid artery were collected to assess IMT in 52 adults with DS and age-, gender-, and race-matched adults without DS (27 women, 25 men; mean age 42 ± 5 years). Total body fat, blood pressure, fasting lipid profiles, insulin, glucose, C-reactive protein, homocysteine, physical activity, and dietary intake were also assessed. Adults with DS possessed lower IMT (0.43 ± 0.07 vs 0.48 ± 0.09 mm, p <0.001), systolic blood pressure (116 ± 15 vs 125 ± 17 mm Hg, p <0.011), and diastolic blood pressure (59 ± 10 vs 73 ± 9 mm Hg, p <0.001) and higher C-reactive protein (0.58 ± 0.55 vs 0.30 ± 0.42 mg/dl, p <0.003), triglycerides (126.5 ± 55.2 vs 103.8 ± 53.2 mg/dl, p <0.048), and total body fat (37.8 ± 10.2% vs 32.4 ± 11.2%, p <0.002) than controls. Male gender (p <0.001) and physical activity (p = 0.020) were identified as predictors of IMT for adults with DS and fasting insulin (p <0.001), age (p <0.001), gender (p <0.001), fruit and vegetable intake (p = 0.001), low-density lipoprotein cholesterol (p = 0.004), and smoking (p = 0.023) for controls. In conclusion, community residing adults with DS may be protected against atherosclerosis despite elevated total body fat and elevated cardiovascular disease risk factors. Predictors of IMT differed for patients with DS compared to controls, which indicates that patients with DS possess a unique model of atherogenesis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21059445     DOI: 10.1016/j.amjcard.2010.06.079

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

Review 1.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

2.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

3.  Cross-Sectional Study of Arterial Stiffness in Adolescents with Down Syndrome.

Authors:  Andrea Kelly; Sheela N Magge; Rachel Walega; Claire Cochrane; Mary E Pipan; Babette S Zemel; Meryl S Cohen; Samuel S Gidding; Ray Townsend
Journal:  J Pediatr       Date:  2019-06-11       Impact factor: 4.406

4.  Cardiometabolic Risk and Body Composition in Youth With Down Syndrome.

Authors:  Sheela N Magge; Babette S Zemel; Mary E Pipan; Samuel S Gidding; Andrea Kelly
Journal:  Pediatrics       Date:  2019-07-17       Impact factor: 7.124

Review 5.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

6.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

7.  Relationships of Body Composition to Cardiac Structure and Function in Adolescents With Down Syndrome are Different than in Adolescents Without Down Syndrome.

Authors:  Andrea Kelly; Samuel S Gidding; Rachel Walega; Claire Cochrane; Sarah Clauss; Ray R Townsend; Melissa Xanthopoulos; Mary E Pipan; Babette S Zemel; Sheela N Magge; Meryl S Cohen
Journal:  Pediatr Cardiol       Date:  2018-11-01       Impact factor: 1.655

8.  Peripheral blood flow regulation in response to sympathetic stimulation in individuals with Down syndrome.

Authors:  Thessa I M Hilgenkamp; Sang Ouk Wee; Elizabeth C Schroeder; Tracy Baynard; Bo Fernhall
Journal:  Artery Res       Date:  2018-10-24       Impact factor: 0.597

9.  Atherosclerotic Surrogate Markers in Adults With Down Syndrome: A Case-Control Study.

Authors:  Pedro Parra; Ramón Costa; Diego Real de Asúa; Fernando Moldenhauer; Carmen Suárez
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-06       Impact factor: 3.738

Review 10.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.